MATINAS BIOPHARMA HLDGS INC - COM (MTNB)

CUSIP: 576810105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
8,427,805
Share change
-3,101,112
Total reported value
$3,658,048
Price per share
$0.43
Number of holders
36
Value change
-$1,849,798
Number of buys
19
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q2 2018

As of 30 Jun 2018, MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,427,805 shares. The largest 10 holders included VANGUARD GROUP INC, ROYAL BANK OF CANADA, Raymond James Financial Services Advisors, Inc., IFP Advisors, Inc, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, ELEMENT CAPITAL MANAGEMENT LLC, MORGAN STANLEY, Paloma Partners Management Co, and BlueCrest Capital Management Ltd. This page lists 36 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.